From prion diseases to prion-like propagation mechanisms of neurodegenerative diseases

International Journal of Cell Biology

Volumn , Issue , 2013, Pages

  Acquatella Tran Van Ba, Isabelle ^a,b,c   Imberdis, Thibaut ^a,b,c   Perrier, Véronique ^a,b,c  

^a UNIV MONTPELLIER   (France)

^b INSERM   (France)

^c PSL RESEARCH UNIVERSITY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

PRION PROTEIN;

ALZHEIMER DISEASE; AMYLOID PLAQUE; AMYLOIDOSIS; ATAXIA; BOVINE SPONGIFORM ENCEPHALOPATHY; CREUTZFELDT JAKOB DISEASE; DEGENERATIVE DISEASE; FATAL FAMILIAL INSOMNIA; HUMAN; IONIZING RADIATION; NEUROBLASTOMA; NONHUMAN; PARKINSON DISEASE; PATHOGENESIS; PATHOGENICITY; PHYSICAL CHEMISTRY; POINT MUTATION; PRION DISEASE; PRIORITY JOURNAL; PROTEIN AGGREGATION; REVIEW; SENILE PLAQUE; ULTRAVIOLET RADIATION;

EID: 84886679059     PISSN: 16878876     EISSN: 16878884     Source Type: Journal    
DOI: 10.1155/2013/975832     Document Type: Review

References (68)

1. Prusiner S. B., Novel proteinaceous infectious particles cause scrapie. Science 1982 216 4542 136 144 2-s2.0-0020321767 (Pubitemid 12089840)
2. Dormont D., Prion diseases: pathogenesis and public health concerns. FEBS Letters 2002 529 1 17 21 2-s2.0-0037010121 10.1016/S0014-5793(02)03268-4 (Pubitemid 35283905)
3. Will R. G., Ironside J. W., Zeidler M., Cousens S. N., Estibeiro K., Alperovitch A., Poser S., Pocchiari M., Hofmar A., Smith P. G., A new variant of Creutzfeldt-Jakob disease in the UK. The Lancet 1996 347 9006 921 925 2-s2.0-0342951746 10.1016/S0140-6736(96)91412-9
4. Peden A. H., Head M. W., Ritchie D. L., Bell P. J. E., Ironside P. J. W., Preclinical vCJD after blood transfusion in a PRNP codon 129 heterozygous patient. The Lancet 2004 364 9433 527 529 2-s2.0-4043157677 10.1016/S0140- 6736(04)16811-6 (Pubitemid 39070413)
5. Sibbald B., UK patient first to contract vCJD via blood transfusion. Canadian Medical Association Journal 2004 170 7 1087 2-s2.0-2542501619
6. Wroe S. J., Pal S., Siddique D., Hyare H., Macfarlane R., Joiner S., Linehan J. M., Brandner S., Wadsworth J. D., Hewitt P., Collinge J., Clinical presentation and pre-mortem diagnosis of variant Creutzfeldt-Jakob disease associated with blood transfusion: a case report. The Lancet 2006 368 9552 2061 2067 2-s2.0-33845227845 10.1016/S0140-6736(06)69835-8 (Pubitemid 44855106)
7. Gajdusek D. C., Gibbs C. J. Jr., Slow, latent and temperate virus infections of the central nervous system. Research Publications-Association for Research in Nervous and Mental Disease 1968 44 254 280 2-s2.0-0014389503
8. Kimberlin R. H., Scrapie agent: prions or virinos? Nature 1982 297 5862 107 108 2-s2.0-0020481648 10.1038/297107a0
9. Pattison I. H., Jones K. M., The possible nature of the transmissible agent of scrapie. Veterinary Record 1967 80 1 2 9 2-s2.0-0014194776
10. Alper T., Cramp W. A., Haig D. A., Clarke M. C., Does the agent of scrapie replicate without nucleic acid? Nature 1967 214 5090 764 766 2-s2.0-0014211846 10.1038/214764a0
11. Griffith J. S., Self-replication and scrapie. Nature 1967 215 5105 1043 1044 2-s2.0-0014190760 10.1038/2151043a0
12. Prusiner S. B., McKinley M. P., Groth D. F., Scrapie agent contains a hydrophobic protein. Proceedings of the National Academy of Sciences of the United States of America 1981 78 11 6675 6679 2-s2.0-2442490085 (Pubitemid 12214880)
13. Prusiner S. B., Prions. Proceedings of the National Academy of Sciences of the United States of America 1998 95 23 13363 13383 2-s2.0-0032506187 10.1073/pnas.95.23.13363 (Pubitemid 28525623)
14. Riek R., Hornemann S., Wider G., Billeter M., Glockshuber R., Wuthrich K., NMR structure of the mouse prion protein domain PrP(121-231). Nature 1996 382 6587 180 182 2-s2.0-0029937271 10.1038/382180a0 (Pubitemid 26242887)
15. Pan K.-M., Baldwin M., Nguyen J., Gasset M., Serban A., Groth D., Mehlhorn I., Huang Z., Fletterick R. J., Cohen F. E., Prusiner S. B., Conversion of α -helices into β -sheets features in the formation of the scrapie prion proteins. Proceedings of the National Academy of Sciences of the United States of America 1993 90 23 10962 10966 2-s2.0-0027332116 10.1073/pnas.90.23.10962 (Pubitemid 23354348)
16. Govaerts C., Wille H., Prusiner S. B., Cohen F. E., Evidence for assembly of prions with left-handed β -helices into trimers. Proceedings of the National Academy of Sciences of the United States of America 2004 101 22 8342 8347 2-s2.0-2942616602 10.1073/pnas.0402254101 (Pubitemid 38736577)
17. Silveira J. R., Raymond G. J., Hughson A. G., Race R. E., Sim V. L., Hayes S. F., Caughey B., The most infectious prion protein particles. Nature 2005 437 7056 257 261 2-s2.0-24644448839 10.1038/nature03989 (Pubitemid 41294488)
18. Saborio G. P., Permanne B., Soto C., Sensitive detection of pathological prion protein by cyclic amplification of protein misfolding. Nature 2001 411 6839 810 813 2-s2.0-0035859102 10.1038/35081095 (Pubitemid 32588105)
19. Baskakov I. V., Legname G., Prusiner S. B., Cohen F. E., Folding of prion protein to its native alpha-helical conformation is under kinetic control. The Journal of Biological Chemistry 2001 276 23 19687 19690 2-s2.0-0035827614 10.1074/jbc.C100180200
20. Baskakov I. V., Legname G., Baldwin M. A., Prusiner S. B., Cohen F. E., Pathway complexity of prion protein assembly into amyloid. The Journal of Biological Chemistry 2002 277 24 21140 21148 2-s2.0-0037077234 10.1074/jbc.M111402200 (Pubitemid 34952249)
21. Février B., Vilette D., Laude H., Raposo G., Exosomes: a bubble ride for prions? Traffic 2005 6 1 10 17 2-s2.0-12444333644 10.1111/j.1600-0854. 2004.00247.x
22. Vella L. J., Sharples R. A., Lawson V. A., Masters C. L., Cappai R., Hill A. F., Packaging of prions into exosomes is associated with a novel pathway of PrP processing. Journal of Pathology 2007 211 5 582 590 2-s2.0-33947709328 10.1002/path.2145 (Pubitemid 46502435)
23. Caughey B., Lansbury P. T. Jr., Protofibrils, pores, fibrils, and neurodegeneration: separating the responsible protein aggregates from the innocent bystanders. Annual Review of Neuroscience 2003 26 267 298 2-s2.0-0037551741 10.1146/annurev.neuro.26.010302.081142 (Pubitemid 37064935)
24. Simoneau S., Rezaei H., Salès N., Kaiser-Schulz G., Lefebvre-Roque M., Vidal C., Fournier J.-G., Comte J., Wopfner F., Grosclaude J., Schätzl H., Lasmézas C. I., In vitro and in vivo neurotoxicity of prion protein oligomers. PLoS Pathogens 2007 3 8, article e125 2-s2.0-34548782787 10.1371/journal.ppat.0030125 (Pubitemid 47359094)
25. Hainfeller J. A., Brantner-Inthaler S., Cervenakova L., Brown P., Kitamoto T., Tateishi J., Diringer H., Liberski P. P., Regele H., Feucht M., Mayr N., Wessely P., Summer K., Seitelberger F., Budka H., The original Gerstmann-Straussler-Scheinker family of austria: divergent clinicopathological phenotypes but constant PrP genotype. Brain Pathology 1995 5 3 201 211 2-s2.0-0028990981
26. Groschup M. H., Buschmann A., Rodent models for prion diseases. Veterinary Research 2008 39 4, article 32 2-s2.0-50049085479 10.1051/vetres:2008008
27. Solomon I. H., Schepker J. A., Harris D. A., Prion neurotoxicity: insights from prion protein mutants. Current Issues in Molecular Biology 2010 12 2 51 61 2-s2.0-74749105348
28. Bueler H., Aguzzi A., Sailer A., Greiner R.-A., Autenried P., Aguet M., Weissmann C., Mice devoid of PrP are resistant to scrapie. Cell 1993 73 7 1339 1347 2-s2.0-0027319326 10.1016/0092-8674(93)90360-3 (Pubitemid 23201147)
29. Prusiner S. B., Groth D., Serban A., Koehler R., Foster D., Torchia M., Burton D., Yang S.-L., DeArmond S. J., Ablation of the prion protein (PrP) gene in mice prevents scrapie and facilitates production of anti-PrP antibodies. Proceedings of the National Academy of Sciences of the United States of America 1993 90 22 10608 10612 2-s2.0-0027491308 10.1073/pnas.90.22.10608 (Pubitemid 23347091)
30. Mallucci G. R., White M. D., Farmer M., Dickinson A., Khatun H., Powell A. D., Brandner S., Jefferys J. G. R., Collinge J., Targeting cellular prion protein reverses early cognitive deficits and neurophysiological dysfunction in prion-infected mice. Neuron 2007 53 3 325 335 2-s2.0-33846538022 10.1016/j.neuron.2007.01.005 (Pubitemid 46161264)
31. Westaway D., DeArmond S. J., Cayetano-Canlas J., Groth D., Foster D., Yang S.-L., Torchia M., Carlson G. A., Prusiner S. B., Degeneration of skeletal muscle, peripheral nerves, and the central nervous system in transgenic mice overexpressing wild-type prion proteins. Cell 1994 76 1 117 129 2-s2.0-0028052363 10.1016/0092-8674(94)90177-5
32. Sigurdson C. J., Nilsson K. P. R., Hornemann S., Heikenwalder M., Manco G., Schwarz P., Ott D., Rülicke T., Liberski P. P., Julius C., Falsig J., Stitz L., Wüthrich K., Aguzzi A., De novo generation of a transmissible spongiform encephalopathy by mouse transgenesis. Proceedings of the National Academy of Sciences of the United States of America 2009 106 1 304 309 2-s2.0-58549102983 10.1073/pnas.0810680105
33. Watts J. C., Giles K., Stöhr J., Oehler A., Bhardwaj S., Grillo S. K., Patel S., DeArmond S. J., Prusiner S. B., Spontaneous generation of rapidly transmissible prions in transgenic mice expressing wild-type bank vole prion protein. Proceedings of the National Academy of Sciences of the United States of America 2012 109 9 3498 3503 2-s2.0-84857756257 10.1073/pnas.1121556109
34. Hsiao K. K., Scott M., Foster D., Groth D. F., DeArmond S. J., Prusiner S. B., Spontaneous neurodegeneration in transgenic mice with mutant prion protein. Science 1990 250 4987 1587 1590 2-s2.0-0025681138 (Pubitemid 120034374)
35. Telling G. C., Haga T., Torchia M., Tremblay P., DeArmond S. J., Prusiner S. B., Interactions between wild-type and mutant prion proteins modulate neurodegeneration in transgenic mice. Genes and Development 1996 10 14 1736 1750 2-s2.0-0029740354 (Pubitemid 26272380)
36. Chiesa R., Piccardo P., Ghetti B., Harris D. A., Neurological illness in transgenic mice expressing a prion protein with an insertional mutation. Neuron 1998 21 6 1339 1351 2-s2.0-0032427904 10.1016/S0896-6273(00)80653-4 (Pubitemid 29022536)
37. Chiesa R., Piccardo P., Dossena S., Nowoslawski L., Roth K. A., Ghetti B., Harris D. A., Bax deletion prevents neuronal loss but not neurological symptoms in a transgenic model of inherited prion disease. Proceedings of the National Academy of Sciences of the United States of America 2005 102 1 238 243 2-s2.0-11844296730 10.1073/pnas.0406173102 (Pubitemid 40094459)
38. Friedman-Levi Y., Meiner Z., Canello T., Frid K., Kovacs G. G., Budka H., Avrahami D., Gabizon R., Fatal prion disease in a mouse model of genetic E200K Creutzfeldt-Jakob disease. PLoS Pathogens 2011 7 11 2-s2.0-81755183039 10.1371/journal.ppat.1002350 e1002350
39. Jackson W. S., Borkowski A. W., Faas H., Steele A. D., King O. D., Watson N., Jasanoff A., Lindquist S., Spontaneous generation of prion infectivity in fatal familial insomnia knockin mice. Neuron 2009 63 4 438 450 2-s2.0-68949163542 10.1016/j.neuron.2009.07.026
40. Fischer M., Rulicke T., Raeber A., Sailer A., Moser M., Oesch B., Brandner S., Aguzzi A., Weissmann C., Prion protein (PrP) with amino-proximal deletions restoring susceptibility of PrP knockout mice to scrapie. EMBO Journal 1996 15 6 1255 1264 2-s2.0-0029863648 (Pubitemid 26093461)
41. Colby D. W., Wain R., Baskakov I. V., Legname G., Palmer C. G., Nguyen H.-O. B., Lemus A., Cohen F. E., DeArmond S. J., Prusiner S. B., Protease-sensitive synthetic prions. PLoS Pathogens 2010 6 1 2-s2.0-77649214076 10.1371/journal.ppat.1000736 e1000736
42. Gambetti P., Puoti G., Zou W.-Q., Variably protease-sensitive prionopathy: a novel disease of the prion protein. Journal of Molecular Neuroscience 2011 45 3 422 424 2-s2.0-80855131560 10.1007/s12031-011-9543-1
43. Mehlhorn I., Groth D., Stöckel J., Moffat B., Reilly D., Yansura D., Willett W. S., Baldwin M., Fletterick R., Cohen F. E., Vandlen R., Henner D., Prusiner S. B., High-level expression and characterization of a purified 142-residue polypeptide of the prion protein. Biochemistry 1996 35 17 5528 5537 2-s2.0-15844419908 10.1021/bi952965e (Pubitemid 26136530)
44. Zhana H., Stöckel J., Mehlhorn I., Groth D., Baldwin M. A., Prusiner S. B., James T. L., Cohen F. E., Physical studies of conformational plasticity in a recombinant prion protein. Biochemistry 1997 36 12 3543 3553 2-s2.0-0343683408 10.1021/bi961965r (Pubitemid 27143508)
45. Legname G., Baskakov I. V., Nguyen H.-O. B., Riesner D., Cohen F. E., DeArmond S. J., Prusiner S. B., Synthetic mammalian prions. Science 2004 305 5684 673 676 2-s2.0-3442889359 10.1126/science.1100195 (Pubitemid 39006757)
46. Colby D. W., Giles K., Legname G., Wille H., Baskakov I. V., DeArmond S. J., Prusiner S. B., Design and construction of diverse mammalian prion strains. Proceedings of the National Academy of Sciences of the United States of America 2009 106 48 20417 20422 2-s2.0-73949160065 10.1073/pnas.0910350106
47. Makarava N., Kovacs G. G., Bocharova O., Savtchenko R., Alexeeva I., Budka H., Rohwer R. G., Baskakov I. V., Recombinant prion protein induces a new transmissible prion disease in wild-type animals. Acta Neuropathologica 2010 119 2 177 187 2-s2.0-77449142074 10.1007/s00401-009-0633-x
48. Makarava N., Kovacs G. G., Savtchenko R., Alexeeva I., Budka H., Rohwer R. G., Baskakov I. V., Genesis of mammalian prions: from non-infectious amyloid fibrils to a transmissible prion disease. PLoS Pathogens 2011 7 12 2-s2.0-84855290517 10.1371/journal.ppat.1002419 e1002419
49. Makarava N., Kovacs G. G., Savtchenko R., Alexeeva I., Ostapchenko V. G., Budka H., Rohwer R. G., Baskakov I. V., A new mechanism for transmissible prion diseases. Journal of Neuroscience 2012 32 21 7345 7355
50. Wang F., Wang X., Yuan C.-G., Ma J., Generating a prion with bacterially expressed recombinant prion protein. Science 2010 327 5969 1132 1135 2-s2.0-77649213673 10.1126/science.1183748
51. Deleault N. R., Piro J. R., Walsh D. J., Wang F., Ma J., Geoghegan J. C., Supattapone S., Isolation of phosphatidylethanolamine as a solitary cofactor for prion formation in the absence of nucleic acids. Proceedings of the National Academy of Sciences of the United States of America 2012 22 8546 8551
52. Deleault N. R., Walsh D. J., Piro J. R., Wang F., Wang X., Ma J., Rees J. R., Supattapone S., Cofactor molecules maintain infectious conformation and restrict strain properties in purified prions. Proceedings of the National Academy of Sciences of the United States of America 2012 109 28 E1938 E1946
53. Baker H. F., Ridley R. M., Duchen L. W., Crow T. J., Bruton C. J., Induction of β (A4)-amyloid in primates by injection of Alzheimer's disease brain homogenate-comparison with transmission of spongiform encephalopathy. Molecular Neurobiology 1994 8 1 25 39 2-s2.0-0028376473 10.1007/BF02778005
54. Kane M. D., Lipinski W. J., Callahan M. J., Bian F., Durham R. A., Schwarz R. D., Roher A. E., Walker L. C., Evidence for seeding of β -amyloid by intracerebral infusion of Alzheimer brain extracts in β -amyloid precursor protein-transgenic mice. Journal of Neuroscience 2000 20 10 3606 3611 2-s2.0-0034657130 (Pubitemid 30266223)
55. Walker L. C., Bian F., Callahan M. J., Lipinski W. J., Durham R. A., LeVine H., Modeling Alzheimer's disease and other proteopathies in vivo: is seeding the key? Amino Acids 2002 23 1-3 87 93 2-s2.0-0036386817 10.1007/s00726-001-0113-7
56. Meyer-Luehmann M., Coomaraswamy J., Bolmont T., Kaeser S., Schaefer C., Kilger E., Neuenschwander A., Abramowski D., Frey P., Jaton A. L., Vigouret J.-M., Paganetti P., Walsh D. M., Mathews P. M., Ghiso J., Staufenbiel M., Walker L. C., Jucker M., Exogenous induction of cerebral β -amyloidogenesis is governed bf agent and host. Science 2006 313 5794 1781 1784 2-s2.0-33749020837 10.1126/science.1131864 (Pubitemid 44454153)
57. Eisele Y. S., Obermüller U., Heilbronner G., Baumann F., Kaeser S. A., Wolburg H., Walker L. C., Staufenbiel M., Heikenwalder M., Jucker M., Peripherally applied A β -containing inoculates induce cerebral β -amyloidosis. Science 2010 330 6006 980 982 2-s2.0-78149392229 10.1126/science.1194516
58. Morales R., Duran-Aniotz C., Castilla J., Estrada L. D., Soto C., De novo induction of amyloid- β deposition in vivo. Molecular Psychiatry 2011 17 12 1347 1353 2-s2.0-80053437539 10.1038/mp.2011.120
59. Clavaguera F., Bolmont T., Crowther R. A., Abramowski D., Frank S., Probst A., Fraser G., Stalder A. K., Beibel M., Staufenbiel M., Jucker M., Goedert M., Tolnay M., Transmission and spreading of tauopathy in transgenic mouse brain. Nature Cell Biology 2009 11 7 909 913 2-s2.0-67650077008 10.1038/ncb1901
60. de Calignon A., Polydoro M., Suárez-Calvet M., William C., Adamowicz D. H., Kopeikina K. J., Pitstick R., Sahara N., Ashe K. H., Carlson G. A., Spires-Jones T. L., Hyman B. T., Propagation of tau pathology in a model of early Alzheimer's disease. Neuron 2012 73 4 685 697 2-s2.0-84857275902 10.1016/j.neuron.2011.11.033
61. Kordower J. H., Chu Y., Hauser R. A., Freeman T. B., Olanow C. W., Lewy body-like pathology in long-term embryonic nigral transplants in Parkinson's disease. Nature Medicine 2008 14 5 504 506 2-s2.0-43249114934 10.1038/nm1747 (Pubitemid 351655212)
62. Li J.-Y., Englund E., Holton J. L., Soulet D., Hagell P., Lees A. J., Lashley T., Quinn N. P., Rehncrona S., Björklund A., Widner H., Revesz T., Lindvall O., Brundin P., Lewy bodies in grafted neurons in subjects with Parkinson's disease suggest host-to-graft disease propagation. Nature Medicine 2008 14 5 501 503 2-s2.0-43249110200 10.1038/nm1746 (Pubitemid 351655211)
63. Luk K. C., Kehm V. M., Zhang B., O'Brien P., Trojanowski J. Q., Lee V. M., Intracerebral inoculation of pathological alpha-synuclein initiates a rapidly progressive neurodegenerative alpha-synucleinopathy in mice. The Journal of Experimental Medicine 2012 5 975 986
64. Luk K. C., Kehm V., Carroll J., Zhang B., O'Brien P., Trojanowski J. Q., Lee V. M., Pathological alpha-synuclein transmission initiates Parkinson-like neurodegeneration in nontransgenic mice. Science 2012 338 6109 949 953
65. Stohr J., Watts J. C., Mensinger Z. L., Oehler A., Grillo S. K., DeArmond S. J., Prusiner S. B., Giles K., Purified and synthetic Alzheimer's amyloid beta (Abeta) prions. Proceedings of the National Academy of Sciences of the United States of America 2012 27 11025 11030
66. Hawkes C. H., Del Tredici K., Braak H., Parkinson's disease: the dual hit theory revisited. Annals of the New York Academy of Sciences 2009 1170 615 622 2-s2.0-68649095434 10.1111/j.1749-6632.2009.04365.x
67. Chan H. Y. E., Warrick J. M., Andriola I., Merry D., Bonini N. M., Aggregated polyglutamine peptides delivered to nuclei are toxic to mammalian cells. Human Molecular Genetics 2002 11 23 2905 2917 2-s2.0-0036850529 (Pubitemid 35331822)
68. Ren P.-H., Lauckner J. E., Kachirskaia I., Heuser J. E., Melki R., Kopito R. R., Cytoplasmic penetration and persistent infection of mammalian cells by polyglutamine aggregates. Nature Cell Biology 2009 11 2 219 225 2-s2.0-59649095699 10.1038/ncb1830